TOP NEWS: Smith & Nephew shares rise amid first quarter revenue jump

(Alliance News) - Smith & Nephew PLC on Thursday said it saw double-digit first quarter revenue ...

Alliance News 29 April, 2021 | 9:01AM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - Smith & Nephew PLC on Thursday said it saw double-digit first quarter revenue growth, helped by growth across the board, two extra trading days and currency tailwinds.

Shares in the company were 5.3% higher at 1,563.00 pence each in London early on Thursday, the best blue-chip performer.

The medical devices manufacturer said its first quarter revenue surged 12% to USD1.26 billion from USD1.13 billion a year earlier. Smith & Nephew noted a 3.4% foreign exchange benefit, a 1.9% boost from acquisitions and also said the quarter had "two more trading days".

"All three global franchises returned to growth on a reported and underlying basis," the company said.

Orthopaedics revenue climbed 1.6%, Advanced Wound Management rose 9.3% and Sports Medicine & ENT jumped 10%.

Smith & Nephew reinstated guidance for the year ahead. It expects 2021 underlying revenue growth between 10% and 13%. The outlook assumes market conditions improve in the second half, with surgery levels unhurt by Covid-19.

"Our first priority for 2021 is to return to growth and recapture our pre-Covid momentum, and we are encouraged by our early progress through Q1. This was driven not only by surgery volumes moving towards more normal levels in many markets, but also the benefits from better commercial execution, acquired assets, and recent product launches," Chief Executive Officer Roland Diggelmann said.

"Looking ahead, there is improving visibility as vaccine programmes roll out and healthcare systems reopen. Our approach through 2020 to maintain investment is already demonstrating value and I look forward to seeing further evidence of this as the recovery continues."

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Smith & Nephew PLC 1,540.00 GBX 0.75

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement